Spring Mountain Capital

A Nashville-based company providing maternal healthcare services for pregnant mothers with opioid addiction, with a focus on behavioral health and postpartum contraceptive services.

HealthtechBrentwood, US

Justin Lanning(Executive Officer, Promoter)Bradley Towle(Executive Officer, Promoter)

BoardJamie Weston(Executive Officer, Director)Landon Gibbs(Executive Officer, Promoter)in

Genomenon uses AI to read biomedical literature and expert scientists to curate variant- and patient-level genomic evidence, delivering regulatory-grade real-world evidence.

AI & Machine LearningBiotechDigital HealthAnn Arbor, US

Mark Kiel(Executive Officer, Director)Eli Salembier(Executive Officer, Director)Sam Globus(Executive Officer)inDr. Sam Globus(Chief Operating Officer)Michael Klein(Executive Officer, Director)David Gregorka(Director)

Co-investorsBeringeaGreen Park & Golf VenturesID VenturesInvest MichiganIrishAngelsMarram Ventures+1 more

Hiveclass provides remote physical education and youth sports training instruction for kids.

EdTechFuture of WorkWellness & FitnessBridgehampton, US

Joe Titus(Founder)inPaul Suhr(Founder)in

Co-investorsSamvid VenturesTechstarsRethink Capital PartnersRethink Education

Prevalent, a Mitratech product, is an AI-powered third-party risk management (TPRM) platform for assessing, monitoring, and remediating risks across the vendor and supplier lifecycle from onboarding to offboarding.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaSPhoenix, US

Norman W. Menz III(Director)Jonathan Dambrot(Director)Kevin Hickey(Chief Executive Officer)James Ray(Vice President of Finance, Corporate Secretary and Treasurer)Kevin Charest(Director)Doug McNary(Director)

Co-investorsFulcrum Equity PartnersTappan Hill Ventures

Empowering enterprises and governments to reveal cyber risk and quickly orchestrate remediation

Sunnyvale, US

Dr. Srinivas Mukkamala(Executive Officer, Director)Brett Newsome(Executive Officer)

BoardWilliam Dennis Peterson(Director)Mourad Yesayan(Director)inJohn Stewart(Director)Greg Oslan(Director)

Co-investorsEPIC VENTURESPaladin Capital GroupJump CapitalSun Mountain Capital

New York, US

Edward Kim(Executive Officer, Director)Kent Krekorian(Executive Officer)Hal Muchnick(Executive Officer, Director)Mark Peter Davis(Director)

BoardBo Peabody(Director)Benjamin Sun(Director)

Co-investorsMI VenturesSocial StartsAtlas VentureMK Capital

Vergent Bioscience is a clinical-stage biotechnology company developing abenacianine (VGT-309), a tumor-targeted fluorescent imaging agent that helps surgeons see tumors in real time during minimally invasive and robotic-assisted surgery.

BiotechHealthtechMedical DevicesMinneapolis, US

Jeff Julkowski(Director)Douglas Kohrs(Director)Raymond Wong(Director)Jeffrey Yurecko(Executive Officer)John Santini(Executive Officer, Director)Anita Watkins(Director)

Co-investorsColle Capital PartnersWindham Capital Partners

Yunu offers a clinical trial imaging platform that harmonizes imaging workflows, data, and compliance from initial scan through trial submission, cutting turnaround times and reducing manual work.

AI & Machine LearningBiotechHealthtechMedical DevicesSaaS

Jeffrey Sorenson(Chief Executive Officer)Gael Kuhn(Chief Technology Officer)Dr. Gordon Harris(Chief Science Officer)Lindsay Fleming(Chief Marketing Officer)Patrick McNamara(Chief Commercial Officer)in

Co-investorsFirst Analysis